SLC5A2 and heart failure: When asked about the perceived efficacy of SGLT-2 inhibitors in heart failure, 32.8% (n=82) of respondents considered them highly effective, 45.2% (n=113) moderately effective, and 13.6% (n=34) considered them not effective.